PBLS
Parabilis Medicines, Inc.
29.65
-0.37 (-1.23%)
52w low 22.66
42.49 high
35.2% of range
Financial Analysis
| (USD) | Dec 24 | Dec 25 | Trend |
|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | |
| Operating Expenses | 126.12M | 152.08M | |
| R&D | 100.83M | 125.58M | |
| SG&A | 25.30M | 26.50M | |
| Operating Income | -126.12M | -152.08M | |
| EBITDA | -114.33M | -141.87M | |
| Pretax Income | -117.91M | -145.89M | |
| Net Income | -117.91M | -145.89M | |
| EPS Diluted | -2.01 | -1.81 | |
| Diluted Shares | 80.40M | 80.37M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--